Breakthrough Five-Minute Test Offers Hope for Early Endometriosis Detection
Scientists have unveiled a simple five-minute screening tool that could revolutionise the detection of endometriosis, potentially identifying the condition years earlier and offering new hope to millions of women globally. This innovation aims to address the protracted diagnostic delays that currently plague patients, with many enduring nearly a decade of uncertainty before receiving a formal diagnosis.
Understanding Endometriosis and Its Impact
Endometriosis is a chronic condition affecting approximately one in ten women worldwide, equating to around 190 million individuals. It occurs when tissue resembling the lining of the womb grows in other areas of the body, leading to symptoms such as chronic pelvic pain, heavy menstrual bleeding, and fertility issues. These symptoms can severely disrupt daily life, yet many women struggle for years to have their concerns acknowledged by healthcare providers.
In the United Kingdom, the average time to receive an endometriosis diagnosis has now escalated to nine years and four months, a significant increase from the eight-year average recorded in 2020. This delay exacerbates the physical and emotional toll on patients, highlighting an urgent need for improved diagnostic methods.
The SAFE Score: A New Screening Approach
Researchers at the University of Queensland in Australia have developed the Simplified Adolescent Factors for Endometriosis (SAFE) score, a concise questionnaire designed to flag girls and young women who may be at risk and require further investigation. The test involves six straightforward questions covering key symptoms, including pelvic pain, treatment-seeking behaviour, regular use of painkillers, heavy bleeding, painful periods, and family history of the condition.
Responses are used to generate a point-based score, assisting general practitioners in determining whether a referral to a specialist is warranted. Professor Gita Mishra, director of the Australian Women and Girls' Health Research Centre at the University of Queensland, emphasised the tool's potential to reduce diagnostic delays. 'Identifying which patients should be referred and treated is challenging, and improving how patients are diagnosed is a major priority,' she stated. 'By detecting endometriosis earlier—ideally in adolescents soon after their periods begin—we hope the tool will reduce the average six to eight year diagnostic delay so treatment can begin as early as possible.'
Research and Development Insights
The SAFE score was developed using data from over 9,000 participants in the Australian Longitudinal Study on Women's Health, ensuring a robust foundation for its application. Currently, endometriosis is often only confirmed through invasive surgery, though ultrasound and MRI scans are increasingly utilised to aid identification. Earlier diagnosis is critical, as many women are not diagnosed until their late twenties, frequently when attempting to conceive.
The findings have been published in the journal eClinicalMedicine, with the next research phase focusing on testing the tool's efficacy in real-world clinical settings. This development comes amid concerning statistics from Endometriosis UK, which reports that 39% of respondents needed to visit their GP ten times or more before the condition was suspected, and 55% attended accident and emergency departments with symptoms, of whom 46% were sent home without treatment.
Current Treatment Landscape and Advocacy Efforts
There is no cure for endometriosis at present. Treatment typically involves pain management or hormonal options such as the contraceptive pill or Mirena coil, which thin the endometrial lining to suppress growth and alleviate pain. In severe cases where other treatments fail, doctors may recommend early menopause, induced either chemically using gonadotropin-releasing hormone (GnRH) antagonists or surgically via hysterectomy.
Chemically induced menopause may be reversible, whereas surgical intervention is permanent and precludes future childbirth. Patients undergoing early menopause often require hormone replacement therapy to manage symptoms like hot flushes, night sweats, and vaginal dryness.
Endometriosis UK is advocating for all UK governments to commit to reducing the average diagnosis time to one year or less by 2030. This goal includes measures to cut gynaecology waiting lists, enhance menstrual health education, and ensure better training for healthcare professionals, aiming to transform the diagnostic journey for countless women.
